Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.

Garcia-Medina, J. J.; Benitez-Del-Castillo, J.; Rodríguez-Agirretxe, I.; Lopez-Lopez, F.; Moreno-Valladares, A.

2022
Journal of Ocular Pharmacology and Therapeutics

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Department of Ophthalmology, Hospital General Universitario Morales Meseguer, Murcia, Spain; Department of Ophthalmology, Hospital Universitario de Jerez, Jerez de la Frontera Cadiz, Spain; Department of Ophthalmology, Hospital Universitario Donostia, San Sebastian Guipuzcoa, Spain; Instituto Oftalmológico Gomez-Ulla, Santiago de Compostela Galicia, Spain; Department of Ophthalmology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.

View all Glaucoma publications